Skyscape Web Viewer : TNM Cancer Staging Manual : Image Index

View All
N2 is defined as in-transit metastasis (discontinuous from primary tumor; located between primary tumor and draining regional nodal basin, or distal to the primary tumor) without lymph node metastasis
N2 is defined as metastasis in 4 or more regional lymph nodes
N3 is described as fixed or ulcerated regional lymph node metastasis
Natural history of GIST
Neuroendocrine tumors of the small bowel: Kaplan-Meier survival curves by the 8th Edition proposed clinical stage, with a follow-up time of 3 years (2010-2013) and adjusted for patient age
Neuroendocrine tumors of the small bowel: Kaplan-Meier survival curves with 95% confidence intervals by 8th Edition pathological Stage I, n = 142/3366 Data from the National Cancer Data Base (diagnosis years 2010-2013), adjusted for patient age
Neuroendocrine tumors of the small bowel: Kaplan-Meier survival curves with 95% confidence intervals by 8th Edition pathological Stage II, n = 281/3366 Data from the National Cancer Data Base (diagnosis years 2010-2013), adjusted for patient age
Neuroendocrine tumors of the small bowel: Kaplan-Meier survival curves with 95% confidence intervals by 8th Edition pathological Stage III, n =2,136/3366
Neuroendocrine tumors of the small bowel: Kaplan-Meier survival curves with 95% confidence intervals by 8th Edition pathological Stage IV, n =807/3366
Neuroendocrine tumors of the small bowel: Kaplan-Meier survival curves with 95% confidence intervals by the 8th Edition proposed clinical Stage I, n =269/1855
Neuroendocrine tumors of the small bowel: Kaplan-Meier survival curves with 95% confidence intervals by the 8th Edition proposed clinical Stage II, n =240/1855
Neuroendocrine tumors of the small bowel: Kaplan-Meier survival curves with 95% confidence intervals by the 8th Edition proposed clinical Stage III, n =617/1855
Neuroendocrine tumors of the small bowel: Kaplan-Meier survival curves with 95% confidence intervals by the 8th Edition proposed clinical Stage IV, n =729/1855
Observed and overall survival rates for 1,278 patients with urethral cancer classified by the current AJCC staging classification
Observed melanoma-related overall Kaplan-Meier survival rates for metastatic primary choroidal and ciliary body melanomas
Observed melanoma-related overall Kaplan-Meier survival rates for nonmetastatic primary choroidal and ciliary body melanomas3
Observed survival rates for 21,904 cases with carcinoma of the corpus uterus
Osteosarcoma of the appendicular skeleton by stage (6th Edition) (Data from NCDB, 2002-2008)
Osteosarcoma of the pelvis (including the sacrum) by stage (6th Edition) (Data from NCDB, 2002-2008)
Osteosarcoma of the spine (excluding the sacrum) by stage (6th Edition) (Data from NCDB, 2002-2008)
Overall survival (OS) by tumor size among stage II SEER study patients
Overall survival (OS) by tumor size among Stage I SEER study patients
Overall survival according to clinical M-category, AJCC 7th edition
Overall survival according to clinical T-category, AJCC 7th edition
Overall survival according to M1a and M1b descriptors
Overall survival according to M1a descriptors
Overall survival according to number of involved lymph node stations for pathologically staged tumors including all types of resection (R0, R1 and R2)
Overall survival according to pathological N-category, AJCC 7th edition
Overall survival according to pathological T-category, AJCC 7th edition
Overall survival according to the N descriptors for clinically staged tumors (From Asamura et al

NDX